Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$485.99 USD
+4.10 (0.85%)
Updated Jul 9, 2024 04:00 PM ET
After-Market: $486.28 +0.29 (0.06%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: AMC |
6/2024 | $4.09 | 0.41% |
Earnings Summary
For their last quarter, Vertex Pharmaceuticals (VRTX) reported earnings of $4.76 per share, beating the Zacks Consensus Estimate of $4.10 per share. This reflects a positive earnings surprise of 16.10%. Look out for VRTX's next earnings release on August 01, 2024. For the next earning release, we expect the company to report earnings of $4.09 per share, reflecting a year-over-year increase of 5.14%.
Earnings History
Price & Consensus
Zacks News for VRTX
Vertex (VRTX) NDA for Vanza Triple Therapy Accepted by FDA
VRTX: What are Zacks experts saying now?
Zacks Private Portfolio Services